The race to create an oral GLP-1 obesity drug: 4 things to know

Becker's Healthcare December 4, 2024
Alexandra Murphy

The push to develop the first oral GLP-1 receptor drug for obesity is heating up, as three phase 3 drugs race to become the first approved oral treatment for obesity, Global Data reported Dec. 2.

Here are four things to know:

1. There are three FDA approved GLP-1 receptor drugs for obesity: Wegovy, Saxenda and Zepbound. All of these drugs are injectables.
2. A total of 63 oral GLP-1 receptor drugs are in development, with four phase 3 products competing for the first approval of an oral version of the drug.
3. Novo Nordisk’s...

Today's Sponsors

Today's Sponsor